Key result
Compared with 2001, in-hospital mortality in 2011 improved for all NSTEMI patients (PCI OR 0.68; 95% CI 0.56-0.83) and STEMI patients undergoing PCI (OR 0.83; 95% CI 0.73-0.94).
Why the study?
How did in-hospital mortality and costs for AMI hospitalizations change between 2001 and 2011 based on AMI type and intervention received?
Cross-Sectional (n=1,456,154)
Yes
How did in-hospital mortality and costs for AMI hospitalizations change between 2001 and 2011 based on AMI type and intervention received?
Odds Ratio: 0.68 (95% CI 0.56–0.83)
Between 2001 and 2011 in the US, in-hospital mortality improved for all NSTEMI patients but only for STEMI patients who underwent PCI, while hospital costs increased for those receiving interventions.
Mortality gains in select AMI groups may reflect care advances; leaves open causal attribution and relevance beyond 2011.
BACKGROUND: Little is known whether time trends of in-hospital mortality and costs of care for acute myocardial infarction (AMI) differ by type of AMI (ST-elevation myocardial infarction [STEMI] vs. non-ST-elevation [NSTEMI]) and by the intervention received (percutaneous coronary intervention [PCI], coronary artery bypass grafting [CABG], or no intervention) in the United States. METHODS AND RESULTS: We conducted a serial cross-sectional study of all hospitalizations for AMI aged 30 years or older using the Nationwide Inpatient Sample, 2001-2011 (1,456,154 discharges; a weighted estimate of 7,135,592 discharges). Hospitalizations were stratified by type of AMI and intervention, and the time trends of in-hospital mortality and hospital costs were examined for each combination of the AMI type and intervention, after adjusting for both patient- and hospital-level characteristics. Compared with 2001, adjusted in-hospital mortality improved significantly for NSTEMI patients in 2011, regardless of the intervention received (PCI odds ratio [OR] 0.68, 95% CI 0.56 to 0.83; CABG OR 0.57, 0.45 to 0.72; without intervention OR 0.61, 0.57 to 0.65). As for STEMI, a decline in adjusted in-hospital mortality was significant for those who underwent PCI (OR 0.83; 0.73 to 0.94); however, no significant improvement was observed for those who received CABG or without intervention. Hospital costs per hospitalization increased significantly for patients who underwent intervention, but not for those without intervention. CONCLUSIONS: In the United States, the decrease in in-hospital mortality and the increase in costs differed by the AMI type and the intervention received. These non-uniform trends may be informative for designing effective health policies to reduce the health and economic burdens of AMI.
No takes yet. Share an insight, caveat, or question.
Sugiyama et al. (2015) conducted a cross-sectional in acute myocardial infarction (n=1,456,154). Hospitalization in 2011 vs. Hospitalization in 2001 was evaluated on in-hospital mortality (NSTEMI patients undergoing PCI) (OR 0.68, 95% CI 0.56-0.83). Compared with 2001, in-hospital mortality in 2011 improved for all NSTEMI patients (PCI OR 0.68; 95% CI 0.56-0.83) and STEMI patients undergoing PCI (OR 0.83; 95% CI 0.73-0.94).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: